Location San Francisco Bay Area, California, United States Regions West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Dr. Friedhelm Blobel, Ph.D. is President, Chief Executive Officer, Director of SciClone Pharmaceuticals, Inc. He was appointed as Acting Chief Financial Officer of the Company on May 31, 2013. From July 2000 to 2006, Dr. Blobel was President, CEO and a Director of Gryphon Therapeutics, Inc., a South San Francisco based biopharmaceutical company.
Prior to joining Gryphon Therapeutics in July 2000, Dr. Blobel spent two decades as an executive with the Hoechst Group and the Boehringer Mannheim Group including responsibilities in the areas of diabetes and in vitro diagnostics. His roles at these companies included Group President of several product divisions, Chief Technology Officer and General Manager in Tokyo, Japan of a marketing and sales joint venture between Boehringer and Yamanouchi Pharmaceuticals (now Astellas Pharma, Inc.), Senior Vice President of Research and Development Diabetes and Patient Care in Mannheim, Germany as well as in Indianapolis, Indiana. Dr. Blobel earned his doctorate degree with a dissertation in Biochemistry and Microbiology from the University of Hohenheim, Germany and holds an advanced degree in Chemistry from the University of Stuttgart, Germany.
